Alternative-NHEJ Is a Mechanistically Distinct Pathway of Mammalian Chromosome Break Repair by Bennardo, Nicole et al.
Alternative-NHEJ Is a Mechanistically Distinct Pathway of




1, Jeremy M. Stark
1,2*
1Department of Radiation Biology, Beckman Research Institute of the City of Hope, Duarte, California, United States of America, 2City of Hope Graduate School of
Biological Sciences, Duarte, California, United States of America
Abstract
Characterizing the functional overlap and mutagenic potential of different pathways of chromosomal double-strand
break (DSB) repair is important to understand how mutations arise during cancer development and treatment. To this
end, we have compared the role of individual factors in three different pathways of mammalian DSB repair: alternative-
nonhomologous end joining (alt-NHEJ), single-strand annealing (SSA), and homology directed repair (HDR/GC). Considering
early steps of repair, we found that the DSB end-processing factors KU and CtIP affect all three pathways similarly, in that
repair is suppressed by KU and promoted by CtIP. In contrast, both KU and CtIP appear dispensable for the absolute level of
total-NHEJ between two tandem I-SceI–induced DSBs. During later steps of repair, we find that while the annealing and
processing factors RAD52 and ERCC1 are important to promote SSA, both HDR/GC and alt-NHEJ are significantly less
dependent upon these factors. As well, while disruption of RAD51 causes a decrease in HDR/GC and an increase in SSA,
inhibition of this factor did not affect alt-NHEJ. These results suggest that the regulation of DSB end-processing via
KU/CtIP is a common step during alt-NHEJ, SSA, and HDR/GC. However, at later steps of repair, alt-NHEJ is a mechanistically
distinct pathway of DSB repair, and thus may play a unique role in mutagenesis during cancer development and
therapy.
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Introduction
Faithful repair of DNA damage is essential to suppress genetic
instability and tumorigenesis. Conversely, the efficacy of cancer
therapies that utilize DNA damaging agents is likely limited by the
ability of cancer cells to repair such damage. One form of DNA
damage that is prone to causing mutations is a chromosomal
double-strand break (DSB), which can result from DNA
replication, reactive oxygen species, radiation therapy, and some
types of chemotherapy [1]. Characterizing the factors and
pathways of DSB repair is important to understand the process
of mutagenesis during cancer development and treatment.
Non-homologous end joining (NHEJ) is a major pathway of
DSB repair, in which the ends are ligated without the use of
extensive homology. NHEJ appears to comprise both classical-
NHEJ and alternative-NHEJ (alt-NHEJ). Classical-NHEJ requires
a number of factors important for V(D)J recombination, including
the KU70/80 heterodimer (KU), XRCC4, Ligase IV, and DNA-
PKcs [2,3]. Also, classical-NHEJ is predicted to result in minimal
processing of the DSB during repair [3,4]. In contrast, alt-NHEJ
appears to be independent of the above factors, and often results in
a deletion with microhomology at the repair junction [4–12].
Genetic rearrangements consistent with alt-NHEJ have been
observed in chromosomal translocations associated with both
spontaneous and therapy-related cancer [13], and in reversion
mutations of BRCA2 following DNA damage caused by PARP-
inhibition [14]. Thus, alt-NHEJ-derived mutations appear to be
associated with cancer development and may result from some
cancer therapeutics.
In contrast to the NHEJ pathways, homology-directed repair
(HDR/GC) and single-strand annealing (SSA) employ significant
degreesofhomology[15].HDR/GCutilizesahomologoustemplate
for gene conversion (GC) through strand-invasion and nascent DNA
synthesis. HDR/GC is most precise when the identical sister
chromatid is used as the template for repair. Thus, factors that are
important for HDR/GC might be expected to be genome
stabilizing. In contrast to HDR/GC, SSA involves annealing of
homologous single strands tobridge the ends of theDSB,resulting in
a deletion between the repeats. Such deletions have been observed
between homologous segments of ALU elements in germ-line
mutations of several tumor suppressor genes [16].
It is not clear to what degree alt-NHEJ is mechanistically
distinct from SSA or even HDR/GC in mammalian cells. We
sought to examine this mechanistic distinction by developing an
assay for alt-NHEJ repair of a chromosomal DSB, where the
predominant repair product is a 35-nucleotide (nt) deletion with 8
nt of microhomology at the repair junction. We have used this
assay, along with a novel method for inducible control of the I-
SceI endonuclease in stable cell lines, for a comparative genetic
analysis of alt-NHEJ, SSA, and HDR/GC. From these studies, we
found that alt-NHEJ shares KU/CtIP-mediated regulation of end-
processing in common with SSA and HDR/GC, but involves a
unique mechanism for completion of repair with regards to the
role of ERCC1, RAD52, and RAD51.
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We have sought to understand the genetic relationship between
multiple pathways of DSB repair in mammalian cells, since
individual repair pathways show a different propensity for
mutagenesis. For this, we used a series of chromosome-integrated
reporters to monitor the repair of DSBs induced by the I-SceI
endonuclease. Each individual reporter is designed such that
repair of I-SceI-induced DSBs by a specific pathway restores a
GFP expression cassette. Such repair can then be scored in
individual cells as green fluorescence using flow cytometric analysis
(FACS). In each reporter-containing cell line, the generation of
GFP+ cells is confirmed to be absolutely dependent upon
expression of I-SceI (data not shown).
Total-NHEJ Results in a Variety of Repair Products
We have developed two GFP-based chromosomal reporters to
measure NHEJ. The first reporter, EJ5-GFP, detects multiple
classes of NHEJ events, and thus can be considered an assay for
total-NHEJ. We have presented this reporter mostly to provide
context for the other reporter (EJ2-GFP), which is designed to
monitor only alt-NHEJ events. EJ5-GFP is modeled after other
reporters for NHEJ [4,6,9], in that it measures repair between two
tandem endonuclease cut sites. Specifically, EJ5-GFP contains a
promoter that is separated from a GFP coding cassette by a puro
gene that is flanked by two I-SceI sites that are in the same
orientation (Figure 1A). Once the puro gene is excised by NHEJ
repair of the two I-SceI-induced DSBs, the promoter is joined to
the rest of the expression cassette, leading to restoration of the
GFP+ gene. Since the two I-SceI-induced DSBs have complemen-
tary 39 overhangs, such NHEJ could potentially restore an I-SceI
site. Alternatively, NHEJ could fail to restore the I-SceI site, leading
to an I-SceI-resistant site. In addition, a restored I-SceI site could
also be re-cleaved and repaired to result in an I-SceI-resistant site.
To determine the relative contribution of these different NHEJ
products from repair of EJ5-GFP in mammalian cells, we
integrated EJ5-GFP into both wild-type mouse embryonic stem
(ES) cells, as well as transformed human embryonic kidney
(HEK293) cells (see Materials and Methods). Following transient
expression of I-SceI in these cell lines and sorting GFP+ cells, we
amplified the GFP genes and digested the products with I-SceI.
From this analysis, we found evidence of I-SceI-restoration in
approximately 40% of the total products from both ES and
HEK293 cells (Figure 1B). Regarding the other events (60%), we
cloned I-SceI-resistant products from the ES cell line sample and
Figure 1. Total-NHEJ repair between two tandem I-SceI sites
results in a variety of products. (A) EJ5-GFP is shown along with
two classes of NHEJ repair products that can restore a GFP expression
cassette: one that restores an I-SceI site (I-SceI+), and one that is I-SceI–
resistant (I-SceI-). (B) Restoration of the I-SceI site is common in wild-
type cells, but undetectable in KU-deficient cells. EJ5-GFP was
integrated into HEK293, wild-type ES, and Ku70-/- ES cells. Following
transient I-SceI expression in each of these cell lines, GFP+ cells were
sorted, and the GFP genes were amplified from these samples using
primers depicted in (A). Shown are these products digested with I-SceI
or left uncut. (C) The overall frequency of total-NHEJ is unaffected by KU
deficiency. Shown is the frequency of repair of EJ5-GFP resulting in
GFP+ cells from wild-type and Ku70-/- ES cells transfected in parallel
with an I-SceI expression vector. Also shown are Ku70-/- ES cells
cotransfected with both I-SceI and KU70 expression vectors.
doi:10.1371/journal.pgen.1000110.g001
Author Summary
Changes to the sequence of DNA, or mutations, can disrupt
cellular growth control genes, which can lead to cancer
development. Such mutations likely arise from damage to
DNA that is repaired in a way that fails to restore the original
sequence. One type of DNA damage is a chromosomal
double-strand break. We have developed assays to measure
how these breaks are repaired, and also how such repair can
lead to mutations. In particular, we present an assay to
measure a pathway of repair that results in deletion
mutations, often with evidence of short homologous
sequences at the repair junctions (alt-NHEJ). We have
compared the genetic requirements of this repair pathway
in relation to other pathways of repair that use extensive
homology. We find that factors KU and CtIP appear to affect
the initial stages of repair of each of these pathways,
regardless of the length of homology. However, these
pathways appear to diverge at later steps, as relates to the
role of the repair factors RAD52, ERCC1, and RAD51. Given
that mutations observed in some cancer cells are consistent
with alt-NHEJ repair, these mechanistic descriptions provide
models for how such mutations could arise in cancer.
Mechanisms of Alt-NHEJ
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the I-SceI-resistant NHEJ products showed deletions between 8–
27 nucleotides, where the majority of clones (11/12) showed 2–4
nucleotides of microhomology at the junctions. Thus, NHEJ repair
of the EJ5-GFP reporter results in either restoration of the I-SceI
site, or generation of deletion NHEJ events, often with
microhomology at the junctions.
In previous studies with similar NHEJ reporters, KU-deficient
cells showedadefectinrestorationofthe I-SceIsite[4,6].Totestthis
notion further, we integrated EJ5-GFP into Ku70-/- ES cells. We
then transfected this line with an I-SceI expression vector, and
subsequently measured the frequency of NHEJ events that resulted
in a GFP+ gene, and quantified the restoration of the I-SceI site as
described above. In these experiments, we found that Ku70-/- ES
cells showed approximately equivalent overall frequencies of repair
relative to wild-type cells (2.2% and 2.5% respectively, Figure 1C).
However, PCR analysis of the repair products in the Ku70-/- cells
showed only I-SceI-resistant products (Figure 1B). These results
suggest that restoration of the I-SceI site during NHEJ repair is
absolutely KU-dependent, but that I-SceI-resistant NHEJ events are
KU-independent. In summary, EJ5-GFP provides an assessment of
total-NHEJevents,whichcomprisesbothKU-dependentrestoration
of an I-SceI site, as well as deletion products with some evidence of
microhomology at the junctions.
Alt-NHEJ Is Suppressed by KU in Mammalian Cells
We have chosen to focus on the subset of total-NHEJ events that
show evidence of microhomology at the junctions, also called alt-
NHEJ events. For this, we developed a novel reporter (EJ2-GFP),
which is designed so the GFP+ products would predominantly
reflect a discrete alt-NHEJ event. This reporter contains a single
expression cassette for an N-terminal tag (NLS/Zinc-finger, [17])
fused to GFP, except the coding sequence is disrupted between the
tag and GFP by an I-SceI site followed by stop codons in all three
reading frames (Figure 2A). As well, the I-SceI site and stop codons
are flanked by 8 nts. of microhomology, which if annealed during
alt-NHEJ would restore the coding frame between the tag and
GFP, and cause a 35 nt deletion. This alt-NHEJ repair product
also generates an XCM1 restriction site.
We determined the contribution of the XCM1+ product
relative to total GFP+ repair products of EJ2-GFP, as integrated
in ES and HEK293 cells. For this, we sorted GFP+ cells that
resulted from I-SceI expression, amplified the GFP genes by PCR,
and digested the amplification products with XCM1. From these
experiments, we found that the XCM1+ product accounts for
approximately 85% of the total repair products in both ES and
293 cells (Figure 2A and 2B). In addition to this predominant
repair event, GFP+ products derived from EJ2-GFP also include a
few minor repair events, which we identified by sequencing of
cloned PCR products (Figure 2A and 2B; see Table S2). For
instance, one minor repair event involves a 23 nt deletion with no
evidence of microhomology at the junctions (approximately 10%
of total events). The final set of events showed larger deletions,
which ranged between 140–350 nt and showed microhomology at
the repair junctions (approximately 5%). The larger deletion
products apparently restore a GFP+ cassette because the GFP start
codon was placed proximal to the transcription start site
(unpublished data). In summary, while GFP+ products derived
from EJ2-GFP can include some minor repair events, the
predominant event (XCM1+) involves 8 nt of microhomology
and a 35 nt deletion, which is characteristic of alt-NHEJ [4].
From previous studies [4,6], and the above experiments with
EJ5-GFP (Figure 1B and 1C), alt-NHEJ appears to be KU-
independent. To investigate this notion further, we compared the
efficiency of EJ2-GFP repair in wild-type and Ku70-/- ES cells
following transfections with an I-SceI expression vector. We found
that the Ku70-/- cells exhibited a 4-fold increase in the restoration
of the GFP+ gene over wild-type cells, and that this increase was
reversed by co-transfection of a KU70 expression vector
(Figure 2C). Furthermore, analysis of GFP+ products from
Ku70-/- showed a similar pattern as wild-type cells, in that the
XCM1+ alt-NHEJ product was predominant (Figure 2B). Thus,
the alt-NHEJ repair events measured by EJ2-GFP are not only
KU-independent, but also appear to be inhibited by KU. In
relation to other pathways, KU also suppresses HDR/GC and
SSA, as described previously [18], and as confirmed in parallel
experiments with EJ2-GFP (Figure 2C, see Figure 3). Given that
KU-deficiency can lead to elevated DSB end-processing [19,20],
these results raise the possibility that alt-NHEJ, SSA, and HDR/
GC share such end-processing as a common intermediate.
Inducible System for I-SceI in Stable Cell Lines
To continue to test the above hypothesis, we sought to perform
siRNA experiments in HEK293 cells with the DSB reporters.
However, we first would like to describe a novel technological
approach for such siRNA experiments. In general, use of I-SceI-
based reporters for such experiments would require transfection of
the siRNA followed by a second transfection of the I-SceI-
expression vector. Such serial transfections appear to cause
increased toxicity, which can lead to variability between
experiments (unpublished observations).
Thus, we have developed a method for inducible activation of I-
SceI in stable mammalian cell lines to bypass the need for a second
transfection during siRNA experiments. Specifically, we used a
mutant form of the estrogen receptor ligand binding domain,
where in the absence of 4-hydroxytamoxifen (4OHT), this domain
(TAM) appears to restrict access of fused proteins to chromosomes,
while addition of 4OHT releases this restriction [21]. We made a
series of expression vectors for fusion proteins between the TAM-
domain and I-SceI (see Figure S1), and we chose to continue with
an expression vector for TAM fused to both ends of I-SceI: TAM-
I-SceI-TAM (TST).
We generated stable cell lines expressing the TST fusion protein
using a wild-type ES cell line and an HEK293 cell line, each
containinganintegratedcopyoftheDR-GFPreporter(seeMaterials
and Methods).Repair of DR-GFP bythe HDR/GCpathway results
in the restoration of a GFP gene (Figure 3A), as previously described
in mouse embryonic stem (ES) cells [18]. Following establishment of
the TST-expressing cell lines, we analyzed 4OHT-dependent
activation of I-SceI, as measured by GFP+ cells. From these
experiments, we found low background levels of GFP+ cells from
untreated samples, whereas 4OHT treatment resulted in an
approximate 50-fold and 10-fold induction of GFP+ cells in ES
cells and HEK293 cells, respectively (Figure 3B). Furthermore, we
found that the low background levels were stable for at least 4-6
weeks of continuous culture (unpublished data).
To measure not only HDR/GC, but also other repair pathways
using this method, we subsequently developed similar TST stable
cell lines with HEK293 cells containing the EJ2-GFP, EJ5-GFP,
and SA-GFP reporters (see Materials and Methods). The SA-GFP
reporter measures SSA (Figure 3C), as previously described in ES
cells [18]. As discussed in this previous report, while it is formally
possible that HDR/GC associated with crossing-over (CO) could
also result in a GFP+ product from SA-GFP, two lines of evidence
strongly suggest that CO events provide a negligible contribution
to this assay. For one, multiple independent analyses have shown
that CO during DSB repair in mammalian cells occurs at a
frequency of less than 1% of the efficiency of the GFP+ repair
Mechanisms of Alt-NHEJ
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strand-exchange factors (BRCA2/RAD51) causes a significant
increase in the efficiency of GFP+ repair of SA-GFP [18], which is
inconsistent with a CO mechanism. In summary, we have
generated HEK293 cell lines with stable expression of an inducible
I-SceI (TST) and four different reporters to measure alt-NHEJ
(EJ2-GFP), total-NHEJ (EJ5-GFP), SSA (SA-GFP), and HDR/GC
(DR-GFP).
The End-Processing Factor CtIP Promotes alt-NHEJ, SSA,
and HDR/GC, But Is Dispensable for the Absolute Levels
of total-NHEJ
As described above, we sought to examine whether DSB end-
processing may be a common mechanistic step in alt-NHEJ, SSA,
and HDR/GC. For this, we focused on the factor CtIP [24],
which is important for processing DSBs into ssDNA, detected as
Figure 2. Alt-NHEJ is suppressed by KU. (A) EJ2-GFP is shown with 3 NHEJ products that are found to result in GFP+ cells. Shown in the ovals are
the relative contributions of these products, based on the analysis shown in (B). The predominant GFP+ product, labeled Xcm1+, uses 8 nts of
homology flanking the I-SceI site to generate an XCM1 site, resulting in a 35 nt deletion. (B) Analysis of EJ2-GFP repair products that restore the GFP+
gene. EJ2-GFP was integrated into HEK293, wild-type ES, and Ku70-/- ES cells. Using the primers shown in (A), the GFP genes were amplified from the
parental ES EJ2-GFP cell line, and also from sorted GFP+ cells from each of the above cell lines following transient I-SceI expression. Shown are these
amplification products, which were either uncut or cut with XCM1. (C) Repair by alt-NHEJ (EJ2-GFP) is suppressed by KU. Shown are the frequencies of
alt-NHEJ repair, following transient I-SceI expression, for the wild-type and Ku70-/- EJ2-GFP cell lines, along with the Ku70-/- line co-transfected with
an expression vector for KU70. Also shown are parallel experiments with the SA-GFP and DR-GFP reporters (see Figure 3). Asterisks denote a statistical
difference in repair efficiency between Ku70-/- versus both wild-type, as well as Ku70-/- with transient expression of KU70 (p,0.0005).
doi:10.1371/journal.pgen.1000110.g002
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Regarding repair pathways, CtIP appears important for HDR/
GC in both human cells and S. pombe, but is dispensable for
plasmid end joining in S. pombe [25,27]. We tested the hypothesis
that CtIP in mammalian cells promotes not only HDR/GC, but
also alt-NHEJ and SSA.
For this,we performed siRNA knock-downofCtIP inthe relevant
HEK293 cell lines with individual reporters and stable expression of
the inducible I-SceI protein (TST). We knocked-down CtIP levels
using two different siRNA reagents: a pool of three siRNA duplexes
(siCTIP-p), and a previously described single unique siRNA duplex
(siCTIP-1)[25], (see Materials and Methods and Figure S1D). We
compared these CtIP-depleted cells to control cells transfected with a
non-targeting siRNA (siCTRL). We transfected each set of siRNAs
into the HEK293 cell lines 48h prior to induction of I-SceI with
4OHT. The induction with 4OHT continued for 24h, and we
assayed repair frequencies (%GFP+ cells) 3d after the start of the
4OHT treatment. We confirmed reduction in CtIP mRNA for both
siCTIP-p and siCTIP-1 by RT-PCR of RNA isolated from parallel
transfections at the onset of 4OHT addition (see Materials and
Methods; unpublished data).
From these experiments, we observed that HDR/GC, alt-
NHEJ, and SSA were all significantly reduced in CtIP-depleted
cells treated with either siCTIP-p (1.9-fold, 1.7-fold and 1.6-fold,
respectively; Figure 3D) or siCTIP-1 (1.9-fold for each pathway;
Figure 3D). In contrast, the absolute level of total-NHEJ was
slightly increased in CtIP-depleted cells using either siCTIP-p or
siCTIP-1 (1.3-fold and 1.4-fold, respectively; Figure 3D). Thus,
CtIP appears to promote HDR/GC, alt-NHEJ, and SSA, but is
dispensable for total-NHEJ. We suggest that CtIP-mediated DSB
end-processing is important to generate ssDNA for the later steps
of repair by HDR/GC, alt-NHEJ, and SSA.
Alt-NHEJ Is Mechanistically Distinct from SSA and HDR/
GC During Late Steps of Repair
We also considered how alt-NHEJ might diverge from SSA and
HDR/GC at later mechanistic steps. In particular, we addressed
how factors important for completion of SSA may influence alt-
NHEJ, since both pathways often involve annealing of flanking
homology and subsequent processing of non-homologous single-
stranded tails.
Regarding SSA, these annealing and processing steps appear to
be promoted by RAD52 and ERCC1, since cells deficient in these
factors show a decreased level of SSA [18], and also because these
factors possess relevant in vitro activities. RAD52 can function in
vitro to directly promote homologous strand annealing, and also to
mediate RAD51 function during strand exchange [28]. Though,
only the strand annealing activity would be expected to be
important for SSA in mammalian cells, since RAD51 appears to
inhibit SSA [18]. ERCC1/XPF is a structure-specific endonucle-
ase that catalyzes 59 excision during nucleotide excision repair
[29]. In addition, this complex shows efficient cleavage of 39
overhangs, which could promote processing of non-homologous
single-stranded tails during DSB repair [30]. Furthermore,
ERCC1/XPF can form a complex with RAD52, which may
suggest that single-strand tail processing and annealing may be
coordinated by this complex during repair [31].
To directly examine the role of RAD52 and ERCC1 in alt-
NHEJ, we integrated EJ2-GFP into Rad52-/- and Ercc1-/- ES cells
(see Materials and Methods), and determined the fold-change in
repair resulting from complementation with the relevant expres-
sion vector (i.e. RAD52 or ERCC1). Specifically, we transfected
cells with an I-SceI expression vector along with either the relevant
complementation vector or empty vector, and then assayed repair
three days later as in Figure 2C. As well, previously described
Rad52-/- and Ercc1-/- ES cell lines with DR-GFP and SA-GFP
[18] were transfected in parallel. These experiments showed that
the efficiency of SSA (SA-GFP) increased upon complementation
with each of the relevant expression vectors (3.8-fold for ERCC1,
Figure 4A; 1.9-fold for RAD52, Figure 4B). In contrast, the
Figure 3. An inducible system for I-SceI in stable cell lines used
to show that siRNA-mediated disruption of CtIP affects
multiple repair pathways. (A) Shown is the structure of the DR-
GFP reporter along with the HDR/GC repair product that results in GFP+
cells, as described previously in ES cells [18]. (B) System for inducible
control of I-SceI in stable cell lines. Cell lines were established with ES
cells and HEK293 cells that contain the DR-GFP reporter and stable
expression of the TAM-I-SceI-TAM (TST) fusion protein. These cell lines
were either left untreated, or treated with 4-hydroxytamoxifen (4OHT)
for a limited time (8 h for ES, 24 h for HEK293), and analyzed 3 d after
starting the treatment. Shown are flow cytometric (FACS) profiles of 10
5
cells, where green fluorescence is plotted on the y-axis and auto orange
fluorescence is on the x-axis. (C) Shown is the structure of SA-GFP
reporter along with the GFP+ product of SSA repair. As discussed
previously, HDR/GC associated with crossing over does not likely
contribute significantly to this assay [18]. (D) CtIP promotes alt-NHEJ,
SSA and HDR, but is dispensable for total-NHEJ. HEK293 cell lines with
individual reporters were exposed to control siRNA (siCTRL), a pool of
three CtIP-targeting siRNAs (siCTIP-p), or a distinct single CtIP-targeting
siRNA (siCTIP-1). Subsequently, I-SceI was activated by 4OHT, and repair
was measured as in (B). Shown are repair frequencies relative to the
mean value of siCTRL samples treated in parallel. Asterisks denote a
statistical difference from siCTRL with the substrates EJ2-GFP, SA-GFP,
DR-GFP, and EJ5-GFP for both siCTIP-p (p,0.0001, p=0.0012,
p,0.0001, and p=0.0009, respectively) and siCTIP-1 (p=0.0021,
p=0.0002, p,0.0001, and p=0.0023, respectively).
doi:10.1371/journal.pgen.1000110.g003
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complementation with the expression vector for ERCC1 (1.5-fold,
and 1.4-fold, respectively; Figure 4A), and mildly decreased by
complementation with RAD52 (1.4-fold reduced, and 2-fold
reduced, respectively; Figure 4B). These absolute measurements of
alt-NHEJ could include any of the products that result in a GFP+
gene (see Figure 2A). Notably, while ERCC1 complementation
promotes each pathway to some extent, the effect is significantly
greater for SSA, as compared to alt-NHEJ and HDR/GC (2.5-fold
and 2.7-fold, respectively). These results indicate that alt-NHEJ is
mechanistically distinct from SSA, in that this pathway is both less
dependent upon ERCC1 and is not promoted by RAD52.
Finally, since the above studies showed several mechanistic
similarities between alt-NHEJ and HDR/GC, we next considered
a probable mechanistic distinction between these pathways.
Namely, we suspected that alt-NHEJ might not require RAD51-
mediated strand-exchange. To examine this, we used two
dominant negative inhibitors of RAD51: BRC3 and RAD51-
K133R. BRC3 is a short peptide derived from BRCA2 that can
inhibit RAD51 function [32]. RAD51-K133R is a mutant peptide
defective in ATP-hydrolysis that results in hyper-stable strand
invasion intermediates [33]. We tested the effect of these peptides
on repair of the EJ2-GFP, DR-GFP, and SA-GFP reporters in
otherwise wild-type ES cells. For each cell line, we co-transfected
the I-SceI expression vector along with vectors expressing either
BRC3 or RAD51-K133R, and compared the efficiency of repair
relative to cells transfected with I-SceI and empty vector. From
these experiments, BRC3 and RAD51-K133R resulted in a 2.3-
fold and 6-fold decrease in HDR/GC, respectively, and a 1.4-fold
and 1.8-fold increase in SSA, respectively (Figure 4C), which is
consistent with previous results [18]. In contrast, from parallel
transfections with the EJ2-GFP ES cell line, BRC3 and RAD51-
K133R showed no significant effect on alt-NHEJ repair
(Figure 4C). Thus, alt-NHEJ is distinct from HDR/GC and
SSA, in that it is not affected by disruption of RAD51 function. In
summary, alt-NHEJ shows a number of mechanistic distinctions
from SSA and HDR/GC during later steps of repair.
Discussion
Chromosomal DSBs can be repaired by a variety of pathways
with distinct mechanistic requirements and potentials for muta-
genesis. Given the role of mutagenesis during cancer development
and treatment, it will be important to understand the mechanistic
overlap of these pathways in detail. To this end, we have identified
some mechanistic commonalities and differences between three
DSB repair pathways: alt-NHEJ, SSA, and HDR/GC (Figure 5).
To begin with, each of these pathways appears to be similarly
affected by factors implicated in the control of DSB end-
processing, in that they are each suppressed by KU and promoted
by CtIP. Such DSB end-processing probably involves 59 to 39
resection, as has been directly observed to extend several kilobases
Figure 4. The roles of ERCC1, RAD52, and RAD51 during alt-
NHEJ, HDR/GC, and SSA. (A) While ERCC1 significantly promotes
SSA, it plays a minor role in HDR/GC and alt-NHEJ. Ercc1-/- ES cell lines
with EJ2-GFP, SA-GFP, and DR-GFP were transfected with an I-SceI
expression vector, along with either an expression vector for ERCC1 or
empty vector (EV). Shown are the levels of repair relative to the mean
value of a parallel set of EV transfections, which allows a direct
comparison of the effect of complementation on the different reporters.
Asterisks denote a statistical difference in repair relative to EV (alt-NHEJ
and SSA, p,0.0001; DR-GFP, p=0.0066), and the dagger denotes a
statistical difference in the level of complementation relative to SA-GFP
(p,0.0001). (B) RAD52 promotes SSA but not HDR/GC or alt-NHEJ.
Rad52-/- ES cell lines with the reporters shown in (A) were transfected
with an I-SceI expression vector, along with either an expression vector
for RAD52 or empty vector. Shown are levels of repair as described in
(A). Asterisks denote a statistical difference in repair relative to EV (alt-
NHEJ, p=0.0003; SA-GFP and DR-GFP, p,0.0001). (C) RAD51 promotes
HDR/GC, inhibits SSA, and plays no clear role in alt-NHEJ. Wild-type ES
cell lines with each of the reporters were cotransfected with an I-SceI
expression vector along with either an expression vector for a BRC3
peptide derived from BRCA2, an expression vector for RAD51-K133R, or
EV [18]. Shown are levels of repair calculated relative to EV as in (A).
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end-processing has yet to be determined in vertebrate cells. For
example, it is possible that ssDNA could be formed via chromatin
remodeling followed by unwinding by a DNA helicase. In any
case, activation of end-processing likely requires bypassing KU-
mediated protection of DSB ends [19,20,35]. Such bypass may be
initiated by disrupting the binding of KU with DNA. Alternatively,
as KU is removed from DSBs, factors could increase the
probability that KU-free ends are then processed, for example,
by promoting open chromatin structures [36], and/or by
activating the end-processing machinery.
CtIP could function via any of these mechanisms during early
steps of repair to promote HDR/GC, alt-NHEJ, and SSA.
However, its ability to bind to the MRE11 complex and promote
its nuclease activity, suggests it may directly promote the end-
processing machinery to generate ssDNA [25,26]. Alternatively,
since CtIP is also a transcription factor [37], it could conceivably
promote DSB end-processing by opening chromatin or affecting
some other upstream process. Notably, CtIP is cell cycle regulated
in mammalian cells and in S. pombe, showing its highest levels in S-
phase through G2/M [27,38,39]. Thus, repair pathways that are
promoted by CtIP, including alt-NHEJ, might be expected to be
more prevalent in these later stages of the cell cycle. In general,
further characterization of the nature and mechanism of end-
processing in mammalian cells will lead to insight into the role of
CtIP in regulating this process during repair. Along these lines, our
findings that CtIP promotes repair of both EJ2-GFP and SA-GFP,
which involve deletions of 35 nt and 2.7 kb, respectively, suggests
that CtIP-mediated DSB end-processing can extend over a
relatively wide-range of sizes.
Following DSB end-processing that results in ssDNA as
described above, the mechanisms of alt-NHEJ, SSA, and HDR/
GC appear to diverge based on how the ssDNA is utilized during
repair. For example, such ssDNA could allow either annealing of
flanking homology for alt-NHEJ and SSA, or RAD51-mediated
strand exchange during HDR/GC. Consistent with this notion,
inhibiting RAD51 function disrupts only HDR/GC, such that
RAD51 assembly on ssDNA likely commits repair to HDR/GC
versus other pathways of repair. Considering the mechanisms of
annealing and 39 end-processing, we have observed that alt-NHEJ
is slightly inhibited by RAD52, and is only moderately promoted
by ERCC1. In contrast, SSA is significantly promoted by both of
these factors. This mechanistic distinction may result from
variations in the distance between homologous sequences, the
length of the homology, and/or the absolute requirement for
homologous annealing. For instance, RAD52 may play a specific
role for annealing extensive regions of homology, and hence only
promote SSA. This mechanism is supported by in vitro studies of
RAD52, showing that its preferred binding substrate appears to be
long stretches of ssDNA, though some binding to small regions of
ssDNA can also be observed [40]. Similarly, the specific role for
ERCC1 during SSA could reflect a necessity for this factor in
cleaving particularly long 39 single-stranded tails; however,
inconsistent with this model, ERCC1/XPF shows significant
cleavage activity on short (15 nt) single stranded tails [30]. Then
again, alt-NHEJ may only rarely involve processing of 39 single-
stranded tails, and thus may often involve other intermediate
structures that could be cleaved by a different nuclease complex.
Notably, with regard to each of these mechanistic steps of alt-
NHEJ, mammalian cells show both similarities and differences
with yeast. For instance, our findings with KU/CtIP in
mammalian cells are consistent with experiments in S. cerevisiae
that showed KU-independence [6] and SAE2-activation [41] of
alt-NHEJ, the latter of which may be relevant to mammalian cells
assuming that SAE2 is a homologue of CtIP [25]. Regarding later
steps of alt-NHEJ, the XPF homologue (RAD10)i nS. cerevisiae is
critical for this process [6], whereas RAD52 appears dispensable
[42]. Thus, apart from the increased dependence on ERCC1/
XPF for alt-NHEJ in yeast, these findings are similar to our results
with EJ2-GFP in mammalian cells. In contrast, an S. pombe study
on alt-NHEJ showed the opposite of the S. cerevisiae results, in that
XPF (Rad16) appears dispensable, and RAD52 (Rad22)i s
important [12]. However, these S. pombe experiments were
plasmid-based and involved microhomology very close to the
end of the DSB. Similarly, a plasmid-based alt-NHEJ assay in S.
cerevisiae also showed activation of repair by RAD52 [43]. In
general, these distinctions highlight the notion that the mechanism
of alt-NHEJ may be distinct between mammalian cells and yeast,
but may also be affected by the length of homology, the distance
separating the homologous segments, and/or the context of a DSB
in a plasmid versus a chromosome.
Reflecting such differences, alt-NHEJ pathways have been
categorized using multiple names, each of which reflect certain
features of a defined set of repair events: micro-SSA, micro-
homology-mediated end-joining (MMEJ), KU-independent end-
joining, and backup-NHEJ (B-NHEJ) [4–12]. While it may be
beneficial to find consensus on a particular term, the diversity of
terminology also suggest the presence of multiple subclasses of
NHEJ events. The predominant event measured by EJ2-GFP,
described here as alt-NHEJ, is most similar to MMEJ, in that this
product is KU-independent, shows evidence of microhomology at
the junction, and results in a deletion. In contrast, other events
could be mechanistically more akin to SSA or micro-SSA, with
respect to extent of homology, the distance between homologous
sequences, and RAD52/ERCC1-dependence. Furthermore, some
repair events, while KU-independent, lack evidence of micro-
homology [4,9], such that so-called KU-independent NHEJ or B-
Figure 5. Model for the mechanistic relationships between alt-
NHEJ, SSA, and HDR/GC. Individual genetic factors, shown in ovals,
are placed in the pathways based on the genetic analysis presented
here, and other studies discussed in the text. End processing steps are
shown as 59 to 39 resection, which need not be the precise mechanism
in mammalian cells. The lengths of homologous annealing and 39 end
cleavage are modeled as being less extensive for both alt-NHEJ and
HDR/GC relative to SSA.
doi:10.1371/journal.pgen.1000110.g005
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Further analysis of the mechanisms of this variety of repair events
will continue to clarify the subclasses of NHEJ.
Among these different subclasses of NHEJ, alt-NHEJ/MMEJ
appears to play a significant role in the etiology of mutations that
arise during cancer development and treatment. For instance, a
screen for PARP-inhibitor resistant BRCA2-mutant cells revealed a
set of reversion mutations that are consistent with alt-NHEJ [14].
Thus, combination of PARP-inhibition and simultaneous disruption
ofalt-NHEJmay be effective ineliminating PARP-inhibitorresistant
cancer cells. As supported by our findings with EJ2-GFP, a target for
such therapy may include CtIP [37], whereas disruption of KU-
dependent NHEJ pathways would be predicted to be ineffective.
Though, PARP has been shown to play a role in plasmid-based
NHEJ assays [11], such that it would be important to ensure that alt-
NHEJ is targeted separately from PARP function. Similar to the
BRCA2 example, tumors deficient in ERCC1 would also be
predicted to be relatively proficient at repair of DSBs by alt-NHEJ,
which isconsistentwith thenotion that DSB-inducing agentsmay be
less effective on these tumors than interstrand crosslinking agents
[44]. Finally, since alt-NHEJ appears to play a significant role in
therapy-induced oncogenic chromosomal translocations [13], tar-
geting this pathway, again perhaps via CtIP, may enhance the
efficacy of such therapy. In summary, further analysis of the
mechanisms and mutagenic potential of individual DSB repair
pathways will continue to inform the development of therapeutic
approaches to cancer treatment.
Materials and Methods
Plasmids and Cell Lines
The expression vector for the fusion protein of TAM-I-SceI-
TAM (TST) was generated by PCR amplification of the TAM
domain from TAM-CRE [21], and the I-SceI coding sequence
from pCBASce, which were cloned in frame into pCAGGS-
BSKX [45], as shown in Figure S1. The EJ2SceGFP gene (EJ2-
GFP) was generated by cloning gcctagggataacagggtaattagatga-
caagcc into the XCM1 site of pCAGGS-NZEGFP [46].
EJ2SceGFP was then cloned into pim-DR-GFP [47], and
downstream of pgk-puro to generate pim-EJ2-GFP and EJ2-
GFP-Puro, respectively. For EJ5-GFP, first an I-SceI site was
cloned between the AgeI and BclI sites of pim-EJ2-GFP
(EJ5sceGFP), and also at the HindIII site of pgk-puro (puroSce).
Then, an EcoRI/I-SceI fragment of puroSce was cloned into
EJ5SceGFP, followed by cloning an I-SceI site into the EcoRI site
of this vector. Pim-EJ5-GFP was then completed by replacement
of an EcoRI fragment that was lost in the previous step.
ES cells were cultured as previously described [45], and
HEK293 cells (HEK293-A7, New England Biolabs) were cultured
according to the directions of the supplier, except we used DMEM
high-glucose without phenol red containing Hepes buffer (Invitro-
gen). HEK293 cells were grown on plates treated with 0.01% poly-
lysine (Sigma).
Mouse ES cell lines with DR-GFP and SA-GFP targeted to hprt or
Pim1 were described previously [18,45–47]. Pim-EJ2-GFP was used
totargetthePim1locusofAB2.2wild-typeEScells[48],andKu70-/-
ES cells [49], using methods previously described [45], except
targeting was detected by PCR. Pim-DR-GFP, Hprt-SA-GFP, and
EJ2-GFP-Puro were randomly integrated into HEK293 cells by
electroporation with 1610
7 cells suspended in 800 ml PBS in a
0.4 cm cuvette, followed by pulsing the cells at 250 V, 950 mF, and
selectingsinglecloneswith3 mg/mlpuromycin.Similarly,EJ2-GFP-
Puro was randomly integrated into Ercc1-/- and Rad52-/- ES cells as
above, except using electroporation conditions of 680 V and 10 mF.
Integration of an intact copy of each randomly integrated reporter
was confirmed in single clones by Southern blot analysis with a GFP
fragment as the probe (data not shown).
Stable cell lines expressing TST were generated by electropo-
ration as described above, except with voltages varying between
200–250V, with 20–30 mg of TST expression plasmid and a
selection plasmid. We used two different selection cassettes, with
10 mg of pgk-bsd (gift from Dr. Pentao Liu) for the HEK293 and
5 mg of pmc1neo for the ES cells. Clones were selected in the
relevant antibiotic for 6–10d at 400 mg/ml G418 or 5–10mg/ml
blasticidin (Invitrogen). Individual selected clones were screened
for significant induction of GFP+ cells following 24h treatment
with 0.3 mM and 3 mM 4-hydroxytamoxifen (4OHT, dissolved in
ethanol, Sigma) for ES and HEK293 cells, respectively.
Repair Assays
To measure the repair by transient transfection, 2.5610
4 cells/
cm
2 were plated and transfected the next day with 0.8 mg/ml of
pCBASce mixed with 3.6 ml/ml of Lipofectamine 2000 (Invitro-
gen) along with a variety of other vectors. The KU and RAD52
expression vectors were added at 0.8 mg/ml, the ERCC1 vector
was added at 0.4 mg/ml, the RAD51-K133R vector was added at
0.1 mg/ml, and the BRC3 vector was added at 0.2 mg/ml. For
each experiment, an equivalent amount of empty vector
(pCAGGS-BSKX) was included in the parallel transfections. Each
of these expression vectors have been previously described [18].
GFP positive cells were quantified by flow cytometric analysis
(FACS) 3d after transfection on a Cyan ADP (Dako). Amplifica-
tion of PCR products from sorted GFP+ cells, associated
restriction digests, and quantification of bands were performed
using the primers KNDRF and KNDRR as previously described
for analysis of DR-GFP [50].
To measure repair using the inducible I-SceI protein (TST) in
combination with siRNA-mediated inhibition of CtIP, HEK293
cell lines with each of the reporters and stable expression of TST
were first plated on 24 well plates at 10
5 cells/well. The following
day, the wells were transfected with 70nM siRNA duplex mixed
with 4ul/ml of Lipofectamine 2000 in Optimem (Invitrogen). After
4.5h, transfection complexes were diluted two-fold with media
without antibiotics, and 48h after the initiation of transfection,
4OHT was added at 3 mM for 24h. Three days after 4OHT was
added, the percentage of GFP+ cells was analyzed by FACS as
described above. Knockdown of CtIP levels using the various
siRNAs was confirmed by RT-PCR from RNA samples isolated
from parallel transfections at the time of 4OHT addition (data not
shown). Amplification product was quantified at the threshold
cycle by including SYBR green in the PCR reaction and using an
iQ5 cycler for real-time analysis at the end of each cycle (BioRad).
Products were normalized relative to a primer set directed against
actin. Sequences of the siRNAs siCtIP-p (Santa Cruz Biotechnol-
ogy), and siCtIP-1 [25], and primers for RT-PCR are shown in
Figure S1D.
Repair frequencies are the mean of at least three transfections or
four 4OHT treatments, and error bars represent the standard
deviation from the mean. For some experiments, repair frequen-
cies are shown relative to samples co-transfected with I-SceI and
an empty vector (EV). For this calculation, the percentage of
GFP+ cells from each sample was divided by the mean value of the
EV samples treated in the parallel experiment. Similarly, to
calculate the fold-difference in repair between siRNA-treated and
control-siRNA treated cells, the percentage of GFP+ cells from
each sample was divided by the mean value of control-siRNA
samples from the parallel experiment. Statistical analysis was
performed using the unpaired t-test.
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Figure S1. Details of TAM-I-SceI fusion proteins. (A) Shown
is a schematic for control of TAM-I-SceI fusion proteins using the
hormone 4OHT. (B) Shown are the primer sequences used to
generate expression vectors for TAM-I-SceI fusions from the
parent vectors TAM-CRE, along with pCBASce and pCAGGS-
BSKX. For TAM-I-SceI (TS): a PCR product of TAM-CRE,
using Scetam1 and Scetam7, was cloned into EcoRI/SalI sites of
pCAGGS-BSKX, followed by insertion of a BbsI/AvrII fragment
of pCBASce. For SceTAM (ST), a PCR product of pCBASce,
using Scetam3 and Scetam4, was cloned into EcoRI/BglII sites of
pCAGGS-BSKX, followed by insertion into the BglII/XhoI sites
of this vector with a PCR product of TAM-CRE using Scetam5
and Scetam8 digested with BamHI/SalI. For TamSceTam (TST):
a PCR product of TAM-CRE, using Scetam1 and Scetam7, was
cloned into EcoRI/BbsI sites of ST. (C) We tested each of the ST,
TS, and TST plasmids by transient transfection into the DR-GFP
ES cell line, followed by treatment with 4OHT for 24 h, or
untreated. I-SceI activity is measured by induction of HDR/GC,
as determined 3 d after the 4OHT treatment. In these
experiments, we found that each of the plasmids conferred
approximately equivalent I-SceI activity in the presence of 4OHT,
while the TST fusion showed the lowest background activity in the
absence of 4OHT. (D) Shown are the relevant sequences for the
CtIP siRNA experiments, as described in Materials and Methods.
Found at: doi:10.1371/journal.pgen.1000110.s001 (0.59 MB TIF)
Table S1. Repair junctions for EJ2-GFP. PCR products
shown in Figure 1C from ES cells were cloned into the PCR2.1
vector (Invitrogen) according to the manufacturer’s instructions,
and 12 individual clones with detectable inserts were sequenced
using the M13F primer. Shown is the sequence surrounding the
two I-SceI sites (bold) in the parental EJ5-GFP reporter, along with
repair products from sorted GFP+ cells. Products that were
identified in multiple independent clones are noted in parentheses.
Microhomology found at or near the junctions is underlined, and
the length of microhomology is noted. The sizes of the deletions
relative to the I-SceI+ product are also shown, starting from the 39
end of the coding strand (shown as ATAA/ in the I-SceI+
product).
Found at: doi:10.1371/journal.pgen.1000110.s002 (0.04 MB
DOC)
Table S2. Repair junctions for EJ2-GFP. PCR products
shown in Figure 2B from ES cells were cloned into the PCR2.1
vector (Invitrogen) according to the manufacturer’s instructions,
and individual clones with detectable inserts were sequenced using
the M13F primer. Shown is the sequence surrounding the I-SceI
site (bold) in the parental EJ2-GFP reporter, along with various
repair products from sorted GFP+ cells. The sequence of the
XCM1+ product was confirmed in a clone generated from the
uncut PCR product. The sequence of the 23 nt deletion product
was found in 3 clones from the XCM1-resistant PCR product,
where the junction is marked by a hyphen for clarity. Regarding
the larger deletions, 7 clones in total were sequenced, and one
product was found twice, as noted in the parentheses. Micro-
homology found at or near the junctions is underlined, and the
length of microhomology is noted, where a discontinuous tract of
homology is noted as dis. The sizes of the deletions from the I-SceI
cut site are also shown, starting from the 39 end of the coding
strand (shown as ATAA/ in the parent reporter).
Found at: doi:10.1371/journal.pgen.1000110.s003 (0.04 MB
DOC)
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